Physician profile
Benjamin John Coons
NPI 1720135692
$44,860.36
in general payments reported to CMS, 2019-2025
60 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,476 · 2020: $839 · 2021: $1,088 · 2022: $18K · 2023: $4,182 · 2024: $2,431 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $6,421 · Travel and Lodging: $2,964 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,403.00 |
| Food and Beverage | $6,421.31 |
| Travel and Lodging | $2,964.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Swan Valley Medical Incorporated | $9,582.49 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $6,997.81 | 2022-2025 | |
| Astellas Pharma US INC | $6,552.16 | 2019-2025 | Xtandi, Myrbetriq |
| Avyxa Pharma, LLC | $3,424.38 | 2025 | |
| Medtronic, INC. | $3,255.44 | 2021-2025 | Interstim, Nuro |
| Janssen Biotech, INC. | $2,673.16 | 2021-2025 | Erleada, Carvykti, Rybrevant |
| Ferring Pharmaceuticals INC. | $1,649.51 | 2019-2025 | Adstiladrin |
| Janssen Scientific Affairs, LLC | $1,372.91 | 2025 | |
| Intuitive Surgical, INC. | $873.23 | 2019-2025 | |
| Abbvie INC. | $783.30 | 2021-2025 | Botox, Lupron Depot, Avycaz |
| Boston Scientific Corporation | $674.08 | 2019-2025 | Rezum Generator, Lithovue |
| Sumitomo Pharma America, INC. | $559.05 | 2023-2025 | Orgovyx, Gemtesa |
| Bluewind Medical | $538.48 | 2024 | Revi |
| Neotract INC. | $534.19 | 2019-2020 | |
| Procept Biorobotics Corporation | $474.08 | 2022-2025 | Aquabeam System, Aquabeam Robotic System |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $433.81 | 2019-2024 | Speedicath, Saffron |
| Pfizer INC. | $350.04 | 2021-2025 | |
| Rochester Medical Corporation | $349.95 | 2020-2022 | |
| Urogen Pharma, INC. | $327.08 | 2022-2025 | Jelmyto |
| Progenics Pharmaceuticals, INC. | $276.88 | 2021-2025 | Pylarify |
| Dendreon Pharmaceuticals LLC | $239.87 | 2019-2025 | Provenge |
| Medtronic USA, INC. | $208.87 | 2019-2020 | |
| Myovant Sciences INC. | $206.35 | 2022 | |
| Axonics, INC. | $204.52 | 2022-2023 | Bulkamid |
| Antares Pharma, INC. | $185.87 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Teleflex LLC | $171.02 | 2021-2022 | |
| Palette Life Sciences, INC. | $154.25 | 2022 | |
| Merck Sharp & Dohme LLC | $143.83 | 2020-2025 | Welireg, Keytruda, Lynparza |
| Accord Healthcare, INC. | $143.81 | 2023-2025 | |
| Blue Earth Diagnostics | $133.05 | 2019-2024 | |
| Olympus America INC. | $128.85 | 2019-2024 | Cysto-Nephro Videoscope |
| Allergan, INC. | $119.56 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $117.83 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $109.47 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $107.39 | 2022-2025 | Lynparza |
| Urovant Sciences INC | $91.19 | 2022 | |
| Novartis Pharmaceuticals Corporation | $73.79 | 2024-2025 | |
| Angiodynamics, INC. | $57.27 | 2022-2025 | Nanoknife |
| Laborie Medical Technologies Corp. | $46.54 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| 180 Medical, INC. | $43.78 | 2022-2025 | |
| Hollister Incorporated | $42.48 | 2022 | |
| Travere Therapeutics, INC. | $32.16 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $31.75 | 2024-2025 | |
| Immunitybio, INC. | $31.00 | 2024 | |
| Telix Pharmaceuticals | $30.59 | 2024 | Illuccix |
| Verity Pharmaceuticals INC. | $30.55 | 2023-2025 | Trelstar |
| Myriad Genetic Laboratories, INC. | $29.51 | 2021 | |
| Convatec INC. | $27.95 | 2022 | |
| Sun Pharmaceutical Industries INC. | $26.37 | 2023 | Yonsa |
| Becton, Dickinson and Company | $23.86 | 2023 | Bard Urinary Drainage Bag |
| Novo Nordisk INC | $22.25 | 2024 | Rivfloza |
| Profound Medical Corp. | $21.80 | 2025 | Tulsa-Pro |
| Ambu INC. | $21.35 | 2022 | |
| Innovation Technologies INC | $18.84 | 2025 | Irrisept |
| Cook Medical LLC | $18.83 | 2024 | Cook |
| Agiliti Surgical, INC. | $18.59 | 2019 | |
| Foundation Medicine, INC. | $18.57 | 2022 | |
| Integra Lifesciences Corporation | $16.51 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Halozyme INC | $16.04 | 2023 | |
| Amgen INC. | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$0.05 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Coons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.